<p>, /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, &#34;SenesTech&#34; 或 &#34;公司&#34;), 作为人道主义害虫控制解决方案的领导者，今天宣布任命 Michael Edell 为总裁兼首席执行官，任命自 2026 年 5 月 6 日生效。公司还宣布了董事会领导层的过渡更新，以支持 SenesTech 下一阶段的商业增长和运营执行。</p>
<p>Edell 先生在建立和扩展消费品业务方面拥有良好的业绩记录，具备深厚的电子商务、直销执行和企业对企业渠道开发的专业知识。董事会相信，Edell 先生的运营和商业经验使 SenesTech 能够进一步扩大市场影响力，更高效地拓展收入渠道。</p>
<p>Edell 先生自 2025 年中期以来与 SenesTech 密切合作，最初以顾问身份评估业务并制定以商业增长为重点的战略计划。2025 年 10 月，他被任命为临时首席运营官，负责实施该计划。自那时以来，他简化了运营，将直销收入作为核心增长引擎，并彻底改革了公司的 B2B 过程和组织，以支持更有纪律和可扩展的表现。他还领导了直接管理 Evolve 品牌的老鼠和鼠标产品在亚马逊销售的过渡，并加强了在分销商、全国零售商、市政和其他 B2B 渠道的市场推广工作。</p>
<p>过去几个月实施的运营举措增强了公司的商业基础设施，使 SenesTech 能够更高效地扩展。</p>
<p>&#34;Michael 在担任临时首席运营官期间展现了高度的纪律性和执行力，&#34; SenesTech 主席 Matthew Szot 说。&#34;他在电子商务、客户参与和销售渠道开发方面带来了强大的运营严谨性和实践经验。董事会相信，这正是 SenesTech 在专注于扩大收入渠道、改善转化率和建立更可预测、持久的收入模型时所需要的。我们相信 Michael 是推动有纪律的商业执行和长期股东价值创造的合适领导者。&#34;</p>
<p>&#34;我很感激能在这个重要阶段领导 SenesTech，并对未来的道路感到兴奋，&#34; Edell 先生说。&#34;鉴于我们创新、经过验证和专利产品的实力，我们相信面前有巨大的机会。我们的优先事项很明确：将资源集中在影响最大的商业机会，改善销售执行，并建立可扩展的运营流程。我们特别强调直销和电子商务渠道，包括亚马逊和我们自己的电子商务平台，在这些渠道中，我们相信数据驱动的营销、客户教育和直接参与可以推动高效增长。在这些渠道中，我们非常专注于通过订阅计划扩大经常性收入，这些计划已经在进行中并获得了 traction。同时，我们将继续与分销商、害虫管理专业人士、商业客户和市政当局扩大 B2B 机会。&#34;</p>
<p>&#34;我们相信 Evolve 在一个大型且尚未充分渗透的害虫管理市场中处于良好位置，因为客户越来越寻求有效和可持续的替代方案。我们的重点是改善执行、扩大认知，并使产品更易于理解、购买和在消费者和专业渠道中部署。我们还计划通过增加更多的啮齿动物控制产品来扩展 Evolve 品牌，进一步丰富我们的产品线并加强我们在该类别中的地位。我们将继续专注于有纪律的执行、运营问责和可扩展的增长。&#34;</p>
<p>公司将不再替代 Edell 先生的前临时首席运营官角色，进一步简化公司的组织结构和运营模式。</p>
<p>作为领导层过渡的一部分，公司还宣布了以下董事会更新：</p>
<ul>
<li>Jamie Bechtel 博士将从董事会主席的角色中过渡。与领导层过渡相关，她的临时执行主席角色已结束。Bechtel 博士将继续担任董事会成员，并被任命为提名和公司治理委员会主席以及薪酬委员会主席。</li>
<li>Matthew Szot 被任命为董事会主席。</li>
</ul>
<p>更新后的领导结构反映了董事会对运营执行、问责和强大公司治理的持续关注。</p>
<p><strong>关于 SenesTech, Inc.</strong></p>
<p>SenesTech 致力于通过控制动物害虫种群来创造更健康的环境。公司的开创性产品，包括 Evolve 啮齿动物避孕药，能够无缝融入害虫管理计划，显著提高其有效性，同时减少对传统毒药的依赖。SenesTech 的使命是通过人道、有效和可持续的产品创造更清洁的城市、更高效的企业和更健康的社区。</p>
<p>欲了解更多信息，请访问 https://senestech.com。</p>
<p><strong>安全港声明</strong></p>
<p>本新闻稿包含根据联邦证券法定义的前瞻性声明。前瞻性声明可能包括关于 Edell 先生任命的预期好处；公司的领导层过渡和董事会任命；公司的战略、优先事项和计划；加强电子商务、直接面向消费者、亚马逊、分销商、专业、 municipal 和 B2B 销售渠道的努力；改善销售执行、客户参与、转化、运营指标、运营效率、商业效率和市场地位的努力；技术、数据和人工智能工具的使用；以及 Evolve 的潜在增长、采用和商业表现。这些声明基于当前的预期和假设，并受到可能导致实际结果显著不同的风险和不确定性的影响。可能导致这些差异的因素包括但不限于现场条件的变化、实施实践、市场对我们产品的接受度、我们产品的成功商业化、销售和营销举措的有效性、监管考虑以及 SenesTech 在证券交易委员会的文件中描述的其他风险。前瞻性声明仅在作出之日有效，公司没有义务更新这些声明，除非法律要求。</p>
<p><strong>投资者联系：</strong></p>
<p>Robert Blum, Lytham Partners, LLC</p>
<p>(602) 889-9700, [email protected]</p>
<p><strong>公司联系：</strong> Tom Chesterman, SenesTech, Inc.</p>
<p>(928) 233-7533, [email protected]</p>
<p>来源 SenesTech, Inc.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA3Jk5ld3NJdGVtSWQ9TEE1MzUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDcwODMwUFJfTkVXU19VU1BSX19fX19MQTUzNTM3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA3Jk5ld3NJdGVtSWQ9TEE1MzUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDcwODMwUFJfTkVXU19VU1BSX19fX19MQTUzNTM3"/></p>

SNES

2 倍做多纳斯达克生物技术 ETF - ProShares

纽交所高增长板生物技术指数 ETF - First Trust

标普生物技术 3 倍做多 - Direxion

纳斯达克生物科技指数 ETF - iShares Nasdaq

医药突破 ETF - ALPS

动态生物技术与基因组 ETF - Invesco

标普生物技术 ETF - SPDR

生物科技 ETF - VanEck Vectors

<p>SenesTech, Inc. 已任命 Michael Edell 为总裁兼首席执行官，任命自 2026 年 5 月 6 日生效，旨在增强收入增长和运营执行力。Edell 在消费品业务和电子商务方面拥有丰富的背景，计划专注于直接面向消费者的渠道，并扩大 B2B 机会。领导层的过渡还包括董事会的更新，Matthew Szot 将担任董事会主席。SenesTech 致力于通过创新和人道的解决方案改善害虫管理，并旨在加强其市场存在和收入渠道</p>

<p>, /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, &#34;SenesTech&#34; or the &#34;Company&#34;), a leader in humane pest control solutions, today announced the appointment of Michael Edell as President and Chief Executive Officer, effective May 6, 2026. The Company also announced Board leadership transition updates to support SenesTech's next phase of commercial growth and operational execution.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, &#34;SenesTech&#34; 或 &#34;公司&#34;), 作为人道主义害虫控制解决方案的领导者，今天宣布任命 Michael Edell 为总裁兼首席执行官，任命自 2026 年 5 月 6 日生效。公司还宣布了董事会领导层的过渡更新，以支持 SenesTech 下一阶段的商业增长和运营执行。</p>
</div><p>Mr. Edell brings a proven track record of building and scaling consumer product businesses, with deep expertise in e-commerce, direct-to-consumer execution, and business-to-business channel development. The Board believes Mr. Edell's operational and commercial experience positions SenesTech to further expand its market presence and scale revenue channels more efficiently.</p>
<div class="lb-trans"><p>Edell 先生在建立和扩展消费品业务方面拥有良好的业绩记录，具备深厚的电子商务、直销执行和企业对企业渠道开发的专业知识。董事会相信，Edell 先生的运营和商业经验使 SenesTech 能够进一步扩大市场影响力，更高效地拓展收入渠道。</p>
</div><p>Mr. Edell has worked closely with SenesTech since mid-2025, initially in a consulting capacity to evaluate the business and develop a strategic plan focused on commercial growth. In October 2025, he was appointed Interim Chief Operating Officer to lead its implementation. Since then, he has streamlined operations, prioritized direct-to-consumer revenue as a core growth engine, and overhauled the Company's B2B processes and organization to support more disciplined and scalable performance. He also led the transition to directly managing Amazon sales of the Evolve brand of Rat and Evolve Mouse products and strengthened go-to-market efforts across distributor, national retailer, municipal, and other B2B channels.</p>
<div class="lb-trans"><p>Edell 先生自 2025 年中期以来与 SenesTech 密切合作，最初以顾问身份评估业务并制定以商业增长为重点的战略计划。2025 年 10 月，他被任命为临时首席运营官，负责实施该计划。自那时以来，他简化了运营，将直销收入作为核心增长引擎，并彻底改革了公司的 B2B 过程和组织，以支持更有纪律和可扩展的表现。他还领导了直接管理 Evolve 品牌的老鼠和鼠标产品在亚马逊销售的过渡，并加强了在分销商、全国零售商、市政和其他 B2B 渠道的市场推广工作。</p>
</div><p>The operational initiatives implemented over the past several months have strengthened the Company's commercial infrastructure and positioned SenesTech to scale more efficiently.</p>
<div class="lb-trans"><p>过去几个月实施的运营举措增强了公司的商业基础设施，使 SenesTech 能够更高效地扩展。</p>
</div><p>&#34;Michael has demonstrated a highly disciplined and execution-focused approach during his time as Interim Chief Operating Officer,&#34; said Matthew Szot, Chair of SenesTech. &#34;He brings strong operating rigor and practical experience across e-commerce, customer engagement, and sales channel development. The Board believes this is exactly what SenesTech needs as we focus on scaling revenue channels, improving conversion, and building a more predictable and durable revenue model. We believe Michael is the right leader to drive disciplined commercial execution and long-term stockholder value creation.&#34;</p>
<div class="lb-trans"><p>&#34;Michael 在担任临时首席运营官期间展现了高度的纪律性和执行力，&#34; SenesTech 主席 Matthew Szot 说。&#34;他在电子商务、客户参与和销售渠道开发方面带来了强大的运营严谨性和实践经验。董事会相信，这正是 SenesTech 在专注于扩大收入渠道、改善转化率和建立更可预测、持久的收入模型时所需要的。我们相信 Michael 是推动有纪律的商业执行和长期股东价值创造的合适领导者。&#34;</p>
</div><p>&#34;I appreciate the opportunity to lead SenesTech at this important stage, and I am excited about the path ahead,&#34; said Mr. Edell. &#34;We believe there is a significant opportunity in front of us given the strength of our innovative, proven, and patented products. Our priorities are clear: focus resources on the highest-impact commercial opportunities, improve sales execution, and build scalable operating processes. We are placing particular emphasis on direct-to-consumer and e-commerce channels, including Amazon and our own e-commerce platform, where we believe data-driven marketing, customer education, and direct engagement can drive efficient growth. Within these channels, we are very focused on expanding recurring revenue through subscription programs, which are already underway and gaining traction. At the same time, we will continue to expand B2B opportunities with distributors, pest management professionals, commercial customers, and municipalities.&#34;</p>
<div class="lb-trans"><p>&#34;我很感激能在这个重要阶段领导 SenesTech，并对未来的道路感到兴奋，&#34; Edell 先生说。&#34;鉴于我们创新、经过验证和专利产品的实力，我们相信面前有巨大的机会。我们的优先事项很明确：将资源集中在影响最大的商业机会，改善销售执行，并建立可扩展的运营流程。我们特别强调直销和电子商务渠道，包括亚马逊和我们自己的电子商务平台，在这些渠道中，我们相信数据驱动的营销、客户教育和直接参与可以推动高效增长。在这些渠道中，我们非常专注于通过订阅计划扩大经常性收入，这些计划已经在进行中并获得了 traction。同时，我们将继续与分销商、害虫管理专业人士、商业客户和市政当局扩大 B2B 机会。&#34;</p>
</div><p>&#34;We believe Evolve is well positioned within a large and underpenetrated pest management market as customers increasingly seek effective and sustainable alternatives. Our focus is on improving execution, expanding awareness, and making the product easier to understand, purchase, and deploy across both consumer and professional channels. We also plan to expand the Evolve brand with additional rodent control products, further broadening our offering and strengthening our position within the category. We remain focused on disciplined execution, operational accountability, and scalable growth.&#34;</p>
<div class="lb-trans"><p>&#34;我们相信 Evolve 在一个大型且尚未充分渗透的害虫管理市场中处于良好位置，因为客户越来越寻求有效和可持续的替代方案。我们的重点是改善执行、扩大认知，并使产品更易于理解、购买和在消费者和专业渠道中部署。我们还计划通过增加更多的啮齿动物控制产品来扩展 Evolve 品牌，进一步丰富我们的产品线并加强我们在该类别中的地位。我们将继续专注于有纪律的执行、运营问责和可扩展的增长。&#34;</p>
</div><p>The Company will not replace Mr. Edell's former Interim Chief Operating Officer role, further streamlining the Company's organizational structure and operating model.</p>
<div class="lb-trans"><p>公司将不再替代 Edell 先生的前临时首席运营官角色，进一步简化公司的组织结构和运营模式。</p>
</div><p>As part of the leadership transition, the Company also announced the following Board updates:</p>
<div class="lb-trans"><p>作为领导层过渡的一部分，公司还宣布了以下董事会更新：</p>
</div><ul>
<li>Dr. Jamie Bechtel will transition from her role as Board Chair. In connection with the leadership transition, her role as Interim Executive Chair has concluded. Dr. Bechtel will continue to serve on the Board and has been appointed Chair of the Nominating and Corporate Governance Committee and Chair of the Compensation Committee.</li>
<li>Matthew Szot has been appointed Board Chair.</li>
</ul>
<div class="lb-trans"><ul>
<li>Jamie Bechtel 博士将从董事会主席的角色中过渡。与领导层过渡相关，她的临时执行主席角色已结束。Bechtel 博士将继续担任董事会成员，并被任命为提名和公司治理委员会主席以及薪酬委员会主席。</li>
<li>Matthew Szot 被任命为董事会主席。</li>
</ul>
</div><p>The updated leadership structure reflects the Board's continued focus on operational execution, accountability, and strong corporate governance.</p>
<div class="lb-trans"><p>更新后的领导结构反映了董事会对运营执行、问责和强大公司治理的持续关注。</p>
</div><p><strong>About SenesTech, Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 SenesTech, Inc.</strong></p>
</div><p>SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective and sustainable.</p>
<div class="lb-trans"><p>SenesTech 致力于通过控制动物害虫种群来创造更健康的环境。公司的开创性产品，包括 Evolve 啮齿动物避孕药，能够无缝融入害虫管理计划，显著提高其有效性，同时减少对传统毒药的依赖。SenesTech 的使命是通过人道、有效和可持续的产品创造更清洁的城市、更高效的企业和更健康的社区。</p>
</div><p>For more information, visit https://senestech.com.</p>
<div class="lb-trans"><p>欲了解更多信息，请访问 https://senestech.com。</p>
</div><p><strong>Safe Harbor Statement</strong></p>
<div class="lb-trans"><p><strong>安全港声明</strong></p>
</div><p>This press release contains forward-looking statements within the meaning of federal securities laws. Forward-looking statements may include statements regarding the anticipated benefits of Mr. Edell's appointment; the Company's leadership transition and Board appointments; the Company's strategy, priorities and plans; efforts to strengthen e-commerce, direct-to-consumer, Amazon, distributor, professional, municipal and B2B sales channels; efforts to improve sales execution, customer engagement, conversion, operating metrics, operational efficiency, commercial efficiency and market position; the use of technology, data and AI-enabled tools; and the potential growth, adoption and commercial performance of Evolve. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could cause such differences include, among others, variability in field conditions, implementation practices, market acceptance of our products, the successful commercialization of our products, effectiveness of sales and marketing initiatives, regulatory considerations, and other risks described in SenesTech's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them except as required by law.</p>
<div class="lb-trans"><p>本新闻稿包含根据联邦证券法定义的前瞻性声明。前瞻性声明可能包括关于 Edell 先生任命的预期好处；公司的领导层过渡和董事会任命；公司的战略、优先事项和计划；加强电子商务、直接面向消费者、亚马逊、分销商、专业、 municipal 和 B2B 销售渠道的努力；改善销售执行、客户参与、转化、运营指标、运营效率、商业效率和市场地位的努力；技术、数据和人工智能工具的使用；以及 Evolve 的潜在增长、采用和商业表现。这些声明基于当前的预期和假设，并受到可能导致实际结果显著不同的风险和不确定性的影响。可能导致这些差异的因素包括但不限于现场条件的变化、实施实践、市场对我们产品的接受度、我们产品的成功商业化、销售和营销举措的有效性、监管考虑以及 SenesTech 在证券交易委员会的文件中描述的其他风险。前瞻性声明仅在作出之日有效，公司没有义务更新这些声明，除非法律要求。</p>
</div><p><strong>Investor Contact:</strong></p>
<div class="lb-trans"><p><strong>投资者联系：</strong></p>
</div><p>Robert Blum, Lytham Partners, LLC</p>
<div class="lb-trans"><p>Robert Blum, Lytham Partners, LLC</p>
</div><p>(602) 889-9700, [email protected]</p>
<div class="lb-trans"><p>(602) 889-9700, [email protected]</p>
</div><p><strong>Company Contact:</strong> Tom Chesterman, SenesTech, Inc.</p>
<div class="lb-trans"><p><strong>公司联系：</strong> Tom Chesterman, SenesTech, Inc.</p>
</div><p>(928) 233-7533, [email protected]</p>
<div class="lb-trans"><p>(928) 233-7533, [email protected]</p>
</div><p>SOURCE SenesTech, Inc.</p>
<div class="lb-trans"><p>来源 SenesTech, Inc.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTA3Jk5ld3NJdGVtSWQ9TEE1MzUzNyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MDcwODMwUFJfTkVXU19VU1BSX19fX19MQTUzNTM3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA53537&amp;Transmission_Id=202605070830PR_NEWS_USPR_____LA53537&amp;DateId=20260507"/></p>

08:30 ETSenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels

prnewswire

Senestech

08:30 ET SenesTech 任命 Michael Edell 为总裁兼首席执行官，以推动收入增长和拓展可扩展的销售渠道